Aloyo V J, Ruffin J S, Pazdalski P S, Kirifides A L, Harvey J A
Department of Pharmacology, Medical College of Pennsylvania, Philadelphia, USA.
J Pharmacol Exp Ther. 1995 Apr;273(1):435-44.
The binding of the potent cocaine analog, WIN 35,428 ((-)-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane 1,5-napthalenedisulfonate), was investigated in adult Dutch Belted rabbits by using membrane fractions prepared from fresh caudate nucleus. The consistent finding of this study was that [3H]WIN 35,428 binds to a single class of sites. For example: 1) kinetic analysis revealed that the rate of association and dissociation of [3H]WIN 35,428 was linear; 2) analyses of saturation experiments or homotopic displacement with cold WIN 35,428 by three separate methods statistically favored a one-site model; and 3) heterotropic displacement with drugs that bind to the dopamine (DA) transporter consistently yielded only a single class of binding sites as reflected by a complete displacement of [3H]WIN 35,428 and Hill slopes of approximately 1 (range, 0.89-1.06). The rank order of potencies (Ki) obtained in the competition experiments was: mazindol > nomifensine > (-)-cocaine > bupropion > (-)-norcocaine >> desipramine > DA > (+)-cocaine >> norepinephrine > citalopram > 5-hydroxytryptamine. The affinities of these drugs at the [3H]WIN 35,428 binding site was significantly correlated (r = 0.96, P < .001) with their potencies for inhibiting the uptake of DA, but not the uptake of norepinephrine or 5-hydroxytryptamine. Because [3H]WIN 35,428 binding was fully displaced by cocaine and the displacement was stereoselective, with (-)-cocaine being 200-fold more potent than (+)-cocaine, we conclude that [3H]WIN 35,428 was binding to a single cocaine site. Taken together, these findings indicate that [3H]WIN 35,428 binds to a single cocaine site on the DA transporter of the rabbit with a Kd of 3.2 +/- 0.4 nM and a maximum binding of 0.39 +/- 0.04 pmol/mg of caudate tissue.
采用从新鲜尾状核制备的膜组分,在成年荷兰带兔中研究了强效可卡因类似物WIN 35,428((-)-2-β-甲氧羰基-3-β-(4-氟苯基)托烷1,5-萘二磺酸盐)的结合情况。本研究的一致发现是,[3H]WIN 35,428与单一类别的位点结合。例如:1)动力学分析表明,[3H]WIN 35,428的结合和解离速率呈线性;2)通过三种独立方法对饱和实验或用冷WIN 35,428进行的同型置换分析在统计学上支持单一位点模型;3)用与多巴胺(DA)转运体结合的药物进行的异源置换始终仅产生单一类别的结合位点,这表现为[3H]WIN 35,428的完全置换和Hill斜率约为1(范围为0.89 - 1.06)。在竞争实验中获得的效价(Ki)排序为:马吲哚>诺米芬辛>(-)-可卡因>安非他酮>(-)-去甲可卡因>>地昔帕明>DA>(+)-可卡因>>去甲肾上腺素>西酞普兰>5-羟色胺。这些药物在[3H]WIN 35,428结合位点的亲和力与其抑制DA摄取的效价显著相关(r = 0.96,P <.001),但与去甲肾上腺素或5-羟色胺的摄取无关。由于[3H]WIN 35,428的结合被可卡因完全置换,且这种置换具有立体选择性,(-)-可卡因的效力比(+)-可卡因高200倍,我们得出结论,[3H]WIN 35,428与单一可卡因位点结合。综上所述,这些发现表明,[3H]WIN 35,428以Kd为3.2±0.4 nM、最大结合量为0.39±0.04 pmol/mg尾状核组织的方式与兔DA转运体上的单一可卡因位点结合。